Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Salidroside (Rhodioloside) is a bioactive phenolic glycoside compound isolated from Rhodiola crenulata. It is a prolyl endopeptidase Inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 52.00 | |
10 mg | In stock | $ 85.00 | |
25 mg | In stock | $ 142.00 | |
50 mg | In stock | $ 208.00 | |
100 mg | In stock | $ 313.00 | |
500 mg | In stock | $ 748.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 64.00 |
Description | Salidroside (Rhodioloside) is a bioactive phenolic glycoside compound isolated from Rhodiola crenulata. It is a prolyl endopeptidase Inhibitor. |
In vitro | Salidroside, at dosages of 20, 50, and 100 mg/kg, protects liver tissue from oxidative stress induced by D-galactosamine and LPS (lipopolysaccharide). |
In vivo | Salidroside induces cell cycle arrest at the G1 and G2 phases in various cancer cell lines, while concurrently decreasing levels of CDK4, cyclin D1, cyclin B1, and Cdc2, and upregulating p27(Kip1) and p21(Cip1). Its concentration and time-dependent properties inhibit the growth of diverse human cancer cell lines. Salidroside activates the PI3K/Akt pathway, offering protection against MPP(+)-induced apoptosis in PC12 cells, presenting a potential treatment for Parkinson's Disease (PD). Additionally, by activating the ERK1/2 pathway and inhibiting caspase-3 activation, salidroside reduces cell viability loss and apoptotic cell death in H2O2-stimulated, NGF-differentiated PC12 cells. |
Source |
Synonyms | Rhodioloside |
Molecular Weight | 300.3 |
Formula | C14H20O7 |
CAS No. | 10338-51-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 56 mg/mL (186.5 mM)
Ethanol: 4 mg/mL (13.32 mM)
H2O: 55 mg/mL (183.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Salidroside 10338-51-9 Apoptosis PI3K/Akt/mTOR signaling mTOR POP Inhibitor inhibit Prolyl Endopeptidase (PREP) prolyl oligopeptidase Rhodioloside Mammalian target of Rapamycin inhibitor